Spots Global Cancer Trial Database for locally advanced rectal cancer
Every month we try and update this database with for locally advanced rectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | NCT02353858 | Rectal Cancer Locally Advance... Hyperthermia Hyperthermic Ra... Hyperthermic Ch... Deep Regional H... | Deep regional h... Radiotherapy Chemotherapy (5... | 18 Years - 80 Years | University Hospital Tuebingen | |
Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer | NCT04518280 | Locally Advance... | PD-1 antibody Capecitabine Oxaliplatin Short-course ra... | 18 Years - 70 Years | Fudan University | |
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy | NCT04815694 | Neoadjuvant Che... Locally Advance... Pathological Co... | RT Dose escalat... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer | NCT05079503 | Locally Advance... | GEN-001 | 19 Years - | Korean Cancer Study Group | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer | NCT06204094 | Locally Advance... | node-sparing sh... Sintilimab Capecitabine Oxaliplatin TME surgery watch and wait | 18 Years - 75 Years | Jinhua Central Hospital | |
Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer | NCT00828672 | Locally Advance... | Oxaliplatin Bevacizumab Capecitabine radiotherapy | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial) | NCT03676517 | Locally Advance... | preoperative sh... | 19 Years - 80 Years | Yonsei University | |
Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | NCT03916510 | Locally Advance... | Enadenotucirev Capecitabine Radiotherapy | 18 Years - | University of Oxford | |
A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery | NCT04948762 | Pelvic Exentera... Advanced Pelvic... Locally Advance... | 18 Years - | St Vincent's University Hospital, Ireland | ||
Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence | NCT05054959 | Locally Advance... | consolidation c... induction chemo... | 18 Years - | Institute of Oncology Ljubljana | |
Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer | NCT04518280 | Locally Advance... | PD-1 antibody Capecitabine Oxaliplatin Short-course ra... | 18 Years - 70 Years | Fudan University | |
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer | NCT05576480 | Rectal Cancer Locally Advance... | Short-course ra... Penpulimab CAPEOX TME surgery | 18 Years - 75 Years | Ruijin Hospital | |
Organ Preservation in Locally Advanced Rectal Cancer | NCT03064646 | LOCALLY ADVANCE... | Organ Preservat... | 18 Years - | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | |
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer | NCT05980689 | Locally Advance... | AK104 Capecitabine Neoadjuvant Rad... | 18 Years - 75 Years | Sun Yat-sen University | |
Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study | NCT00842686 | Locally Advance... | bevacizumab, ca... | 18 Years - 80 Years | Institute of Oncology Ljubljana | |
Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer | NCT02964468 | Locally Advance... | 3DCRT treatment... Dose Escalation... | 18 Years - 90 Years | Grupo de Investigación Clínica en Oncología Radioterapia | |
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer | NCT01899118 | Locally Advance... | Preoperative ir... Nimotuzumab Oxaliplatin Capecitabine | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Exercise for Improving Radiotherapy Efficacy in Rectal Cancer | NCT06292975 | Locally Advance... | Supervised Vigo... | 18 Years - | University of Hull | |
Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy | NCT01434147 | Rectal Cancer | preoperative in... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer | NCT01589419 | Locally Advance... | veliparib capecitabine radiation | 18 Years - 99 Years | AbbVie | |
UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer | NCT03824899 | Locally Advance... | Blood concentra... | 18 Years - 75 Years | Fudan University | |
Short-course Preoperative Chemoradiotherapy for Rectal Cancer | NCT01431599 | Rectal Cancer | short-course ra... | 18 Years - 75 Years | Seoul St. Mary's Hospital | |
Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer After Neoadjuvant Radiochemotherapy | NCT03550001 | Rectal Cancer | Injection CNP b... | 18 Years - 75 Years | Peking University People's Hospital | |
Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer | NCT03040180 | Locally Advance... Electrochemothe... Neoadjuvant The... Down Staging | Electrochemothe... EndoVE | 18 Years - | Zealand University Hospital | |
Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer | NCT04906044 | Tislelizumab Locally Advance... Total Neoadjuva... PD-1 | Sintilimab | 18 Years - 80 Years | The First Hospital of Jilin University | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer | NCT00939666 | Locally Advance... | Wait&see or TEM... | 18 Years - | Maastricht University Medical Center | |
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial | NCT05877352 | Locally Advance... Locally Recurre... | Intraoperative ... Extended Margin... | 16 Years - | University Hospital Southampton NHS Foundation Trust | |
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | NCT05253846 | Locally Advance... | Irinotecan Oxaliplatin Lederfolin 5-Fluorouracil Short-course ra... TME | 18 Years - 70 Years | Gruppo Oncologico del Nord-Ovest | |
Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer After Neoadjuvant Radiochemotherapy | NCT03550001 | Rectal Cancer | Injection CNP b... | 18 Years - 75 Years | Peking University People's Hospital | |
RadioPathomics Artificial Intelligence Model to Predict Tumor Regression Grading in Locally Advanced Rectal Cancer | NCT04273451 | Rectal Cancer | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | ||
Nelfinavir, a Phase I/Phase II Rectal Cancer Study | NCT00704600 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | nelfinavir | 18 Years - | Maastricht Radiation Oncology | |
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer | NCT02151019 | Locally Advance... | IMRT | 18 Years - | Cancer Trials Ireland | |
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer | NCT02910843 | Rectal Cancer | Regorafenib Capecitabine Radiotherapy Surgery | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial | NCT02290574 | Locally Advance... | Hyperthermia wi... | 20 Years - | Samsung Medical Center | |
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | NCT05253846 | Locally Advance... | Irinotecan Oxaliplatin Lederfolin 5-Fluorouracil Short-course ra... TME | 18 Years - 70 Years | Gruppo Oncologico del Nord-Ovest | |
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00972881 | Rectal Cancer | cetuximab capecitabine irinotecan hydr... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | University College, London | |
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer | NCT04324567 | Locally Advance... Abdominoperinea... | 18 Years - 100 Years | Oslo University Hospital | ||
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13) | NCT05794750 | Locally Advance... | AK104 injection TME surgery Capecitabine Oxaliplatin | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer | NCT05914766 | Rectal Cancer Self Efficacy | PATHWAYS Enhanced usual ... | 18 Years - | Massachusetts General Hospital | |
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Short-course Preoperative Chemoradiotherapy for Rectal Cancer | NCT01431599 | Rectal Cancer | short-course ra... | 18 Years - 75 Years | Seoul St. Mary's Hospital | |
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer | NCT06281405 | Locally Advance... Neoadjuvant The... | PD-1 antibody Capecitabine Short-course ra... | 18 Years - 70 Years | Fudan University | |
Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | NCT03770689 | Locally Advance... | Peposertib 50 m... Peposertib 100 ... Peposertib 150 ... Peposertib 250 ... Capecitabine Radiotherapy (R... | 18 Years - | EMD Serono | |
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer | NCT06293612 | Locally Advance... Distant Metasta... | No intervention... | - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
SCRT in TNT With or Without Chlorophyllin | NCT05856305 | Rectal Neoplasm... | Chlorophyllin, ... Placebo | 18 Years - 90 Years | Tata Memorial Centre | |
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | NCT03443661 | Locally Advance... | FOLFOXIRI | 18 Years - 70 Years | ChineseAMS | |
Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer | NCT02137356 | Rectal Neoplasm... | standard dose p... standard dose c... dose-escalated ... | 18 Years - | Sheba Medical Center | |
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer | NCT03702985 | Locally Advance... | Radiation Capecitabine Irinotecan Amifostine | 18 Years - 75 Years | Fudan University | |
Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label Study | NCT06234007 | Locally Advance... | Fruquintinib, A... | 18 Years - 75 Years | Wuhan Union Hospital, China | |
Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer | NCT02551471 | Rectal Cancer | Blinded inter-c... MDT (Multidisci... Semi-structured... | 18 Years - | University Hospital, Bordeaux | |
Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | NCT02353858 | Rectal Cancer Locally Advance... Hyperthermia Hyperthermic Ra... Hyperthermic Ch... Deep Regional H... | Deep regional h... Radiotherapy Chemotherapy (5... | 18 Years - 80 Years | University Hospital Tuebingen | |
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer | NCT02151019 | Locally Advance... | IMRT | 18 Years - | Cancer Trials Ireland | |
Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | NCT01489332 | Rectal Cancer | intensified pre... | 18 Years - | Institute of Oncology Ljubljana | |
TIME in Immunotherapy Combined With nCRT for Rectal Cancer | NCT05507112 | Locally Advance... | PD-1 inhibitor Capecitabine Long-course rad... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
Exercise for Improving Radiotherapy Efficacy in Rectal Cancer | NCT06292975 | Locally Advance... | Supervised Vigo... | 18 Years - | University of Hull | |
Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer | NCT00828672 | Locally Advance... | Oxaliplatin Bevacizumab Capecitabine radiotherapy | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness | NCT01859442 | Locally Advance... | Structured resp... Sham group | 18 Years - | Liverpool University Hospitals NHS Foundation Trust | |
Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study | NCT00842686 | Locally Advance... | bevacizumab, ca... | 18 Years - 80 Years | Institute of Oncology Ljubljana | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | NCT01064999 | Rectal Cancer | Oxaliplatin Capecitabine Radiotherapy Surgery | 18 Years - 75 Years | Fudan University | |
Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters | NCT03392584 | Locally Advance... Abdominoperinea... Infection | 18 Years - | Oslo University Hospital | ||
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer | NCT05601505 | Locally Advance... Circulating Tum... | circulating tum... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
RECTAL BOOST Study | NCT01951521 | Rectal Cancer | Boost | 18 Years - | UMC Utrecht | |
Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00972881 | Rectal Cancer | cetuximab capecitabine irinotecan hydr... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | University College, London | |
Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13) | NCT05794750 | Locally Advance... | AK104 injection TME surgery Capecitabine Oxaliplatin | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 | NCT02605265 | Locally Advance... | Radiation Capecitabine Irinotecan Oxaliplatin | 18 Years - 75 Years | Fudan University | |
Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | NCT02217020 | Rectal Cancer | FOLFOXIRI | 18 Years - 70 Years | Sun Yat-sen University | |
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial | NCT02290574 | Locally Advance... | Hyperthermia wi... | 20 Years - | Samsung Medical Center | |
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | NCT05201430 | Rectal Cancer | FOLFOXIRI CapeOX | 18 Years - 75 Years | Fudan University | |
Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer | NCT04670588 | Rectal Cancer | Circulating tum... | 18 Years - | Medical College of Wisconsin | |
The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness | NCT01859442 | Locally Advance... | Structured resp... Sham group | 18 Years - | Liverpool University Hospitals NHS Foundation Trust | |
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer | NCT04411537 | Locally Advance... | PD-1 antibody Capecitabine Irinotecan Neoadjuvant Rad... | 18 Years - 70 Years | Fudan University |